Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.55p
   
  • Change Today:
      0.005p
  • 52 Week High: 17.60
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 920,166
  • Market Cap: £22.85m
  • RiskGrade: 328
  • Beta: 0.01

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £67,651
Lisa Baderoon 583,963 £26,541
Tim Franklin 525,000 £23,861

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £1,141,161
Invesco Ltd 17,872,341 £812,298
Aviva Investors Global 11,285,180 £512,911
Alora Pharmaceuticals LLC 10,909,091 £495,818
M&G Investments 7,600,000 £345,420
Prudential plc 7,600,000 £345,420
Capital Income Builder 4,870,367 £221,358
Dr R Zimmer 4,551,553 £206,868
Odey Asset Management 3,433,319 £156,044
Rhone Trustees (Switzerland) SA 3,386,000 £153,894
Pictet Overseas Trust Corporation Limited 3,287,500 £149,417

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 4.55p
Change Today 0.005p
% Change -0.11 %
52 Week High 17.60
52 Week Low 1.50
Volume 920,166
Shares Issued 502.72m
Market Cap £22.85m
Beta 0.01
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 26-Mar-2026

Time Volume / Share Price
16:17 11,179 @ 4.47p
16:15 30 @ 4.70p
16:04 32 @ 4.70p
15:43 5,000 @ 4.62p
14:46 21,357 @ 4.65p

Immupharma Key Personnel

CFO Ashley Clarke

Top of Page